Novo Nordisk Hungary
In Hungary, diabetes affects more than half a million people and their families, of which 120 to 130 thousand people use insulin. According to the WHO, the number of diabetic patients will double by 2014, ie, every 1 in 10 Hungarian people will be directly affected.Since its establishment in 1923, Novo Nordisk's activities focus on making diabetes and insulin treatment available. With more than 75 years experience of diabetes care, Novo Nordisk is a dominant representative of the growing proportion of cases in response to expanded research, development and disease management programs devoted to financial assets.
| Type: | NORMAL |
| Address: | 1025 Budapest, Felsőzöldmáli u.35. Hungary |
| Website: | http://novonordisk.hu |
| Phone: | +36 325-9161 |
| Fax: | +36 325-9169 |
| Email: | info@novonordisk.hu |